Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabitril in Generalized Anxiety Disorder
NCT00214994Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of tiagabine in generalized anxiety disorder (GAD), sponsored by Cephalon, Inc.. Started Jan 2005; status: completed.
02
Drugs
tiagabine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00214994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00214994.